// App-Quantinova.ai

: Transplant Status Does Not Impact the Selection of Induction Regimens for Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) in the Insight MM Prospective, Observational Study

Researchers

Presenter

  • Saad Z. Usmani

Principal Investigators

  • Xavier Leleu

  • Hans C. Lee

  • Faith E. Davies

  • Caitlin L. Costello

  • Robert M Rifkin

  • Katja Weisel

  • Ajai Chari

  • Noemi Puig

  • Mario Boccadoro

  • Gordon Cook

  • Jesus G. Berdeja

  • Jeffrey A Zonder

  • Michael A. Thompson

  • Rafat Abonour

  • Jorge Vela-Ojeda

  • Roman Hajek

  • Andrew Spencer

  • Jim Omel

  • Brittany Demers

  • Dorothy Romanus

  • Kaili Ren

  • Tomas Skacel

  • Dawn Marie Stull

  • Evangelos Terpos

Medical Centers

  • Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Charlotte, NC

  • Department of Hematology, Clinica São Germano and Santa Casa Medical School, São Paulo, Brazil

  • Pôle Régional de Cancérologie, CHU de Poitiers, Poitiers, France

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Myeloma Institute for Research and Therapy, Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), Little Rock, AR

  • Department of Medicine, Division of Blood and Marrow Transplantation, Moores Cancer Center, University of California, San Diego, La Jolla, CA

  • Hematology Research, US Oncology Research, Rocky Mountain Cancer Centers, Yampa Valley Medical Center, United States, Texas

  • Universitts-Frauenklinik Tubingen, Tubingen, Germany

  • Mount Sinai School of Medicine, New York, NY

  • hematology Division, Hospital Universitaro de Salamanca, Salamanca, Spain

  • Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy

  • Haematology, Clinical Trials Research Unit, NIHR (Leeds) IVD Cooperative, Leeds Teaching Hospital, Leeds, United Kingdom

  • Department of Hematology, Tennessee Oncology and Sarah Cannon Research Institute, Nashville, TN

  • Department of Infectious Diseases, Karmanos Cancer Institute/Wayne State University School of Medicine, Detroit, MI

  • Aurora Cancer Care, Aurora Research Institute, Advocate Aurora Health, Milwaukee, WI

  • Department of Urology, Indiana University School of Medicine, Indianapolis, IN

  • Hematology, Centro Médico Nacional La Raza, Instituto Mexicano del Seguro Social Unidad Médica de Alta Especialidad, Ciudad de México, Mexico

  • Department of Neurosurgery, University Hospital Ostrava, Ostrava, Czech Republic

  • Malignant Haematology and Stem Cell Transplantation Service, The Alfred Hospital/MONASH University/Australian Centre for Blood Diseases, Melbourne, Australia

  • The Central Nebraska Myeloma Support Group, Grand Island, NE

  • Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Deerfield, IL

  • Global Outcomes Research,Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited,Cambridge,United States

  • Global Statistics and Quantitative Sciences, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA

  • Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Deerfield, IL

  • Global Outcomes Research,Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited,Cambridge,United States

  • Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece

Locations

  • United States

  • Brazil

  • France

  • Germany

  • Spain

  • Italy

  • United Kingdom

  • Mexico

  • Czech Republic

  • Australia

  • Greece

Companies

  • Millennium Pharmaceu

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

Phase

  • NA

Study Id's

  • NCT02761187

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved